We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$151M
AUM Growth
-$4.77M
Cap. Flow
+$6.61M
Cap. Flow %
4.38%
Top 10 Hldgs %
51.89%
Holding
243
New
14
Increased
48
Reduced
40
Closed
18
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPS
151
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$66K 0.04%
10,000
XHE icon
152
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
$63K 0.04%
740
PSEC icon
153
Prospect Capital
PSEC
$1.07B
$62K 0.04%
10,000
KPTI icon
154
Karyopharm Therapeutics
KPTI
$43.5M
$55K 0.04%
667
TRHC
155
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$48K 0.03%
10,000
PBI icon
156
Pitney Bowes
PBI
$2.4B
$47K 0.03%
20,000
BGY icon
157
BlackRock Enhanced International Dividend Trust
BGY
$524M
$45K 0.03%
10,000
IVLU icon
158
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
$45K 0.03%
2,276
IDEV icon
159
iShares Core MSCI International Developed Markets ETF
IDEV
$31.7B
$42K 0.03%
860
-110
-11% -$5.92K
VTI icon
160
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$41K 0.03%
226
ATRA icon
161
Atara Biotherapeutics
ATRA
$75.5M
$38K 0.03%
400
VGLT icon
162
Vanguard Long-Term Treasury ETF
VGLT
$10B
$37K 0.02%
593
-3,586
-86% -$247K
WVE icon
163
Wave Life Sciences
WVE
$1.09B
$36K 0.02%
10,000
SCTL
164
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$33K 0.02%
20,000
NCV
165
Virtus Convertible & Income Fund
NCV
$378M
$32K 0.02%
2,500
STIP icon
166
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$32K 0.02%
328
PCY icon
167
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$31K 0.02%
1,858
-13,565
-88% -$254K
GDX icon
168
VanEck Gold Miners ETF
GDX
$22.7B
$29K 0.02%
1,206
SHY icon
169
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$29K 0.02%
363
-290
-44% -$23.9K
EMGF icon
170
iShares Emerging Markets Equity Factor ETF
EMGF
$1.82B
$28K 0.02%
736
OLMA icon
171
Olema Pharmaceuticals
OLMA
$1B
$28K 0.02%
10,000
VOE icon
172
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$27K 0.02%
220
+1
+0.5% +$135
AAIC
173
DELISTED
Arlington Asset Investment Corp.
AAIC
$27K 0.02%
10,000
IAGG icon
174
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$26K 0.02%
545
QUAD icon
175
Quad
QUAD
$536M
$26K 0.02%
10,000

Similar funds

Running Point Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Running Point Capital Advisors held 243 positions worth $151M, down 3.1% from $156M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Running Point Capital Advisors deployed $6.61M of net new capital in Q3 2022, opening 14 new positions and adding to 48 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 56,382 shares worth $1.97M.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $2.07M trimmed.

  • Running Point Capital Advisors's largest Q3 2022 buy was iShares MSCI Emerging Markets ETF: 56,382 shares worth $1.97M.
  • Running Point Capital Advisors added most to State Street SPDR Nuveen ICE High Yield Municipal Bond ETF in Q3 2022, an estimated $3.04M increase.
  • Running Point Capital Advisors's biggest Q3 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $2.07M.
  • Running Point Capital Advisors fully exited Boeing in Q3 2022, selling an estimated $404K.
  • Running Point Capital Advisors's ten largest holdings make up 52% of its $151M portfolio in Q3 2022.
  • Running Point Capital Advisors opened 14 new positions and closed 18 in Q3 2022.
  • Running Point Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $151M.

Based on Running Point Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.